Role of Treatment Cost on Transmission of Multidrug-Resistant Tuberculosis Into Iran

Clin Infect Dis. 2015 Sep 15;61(6):1029-30. doi: 10.1093/cid/civ459. Epub 2015 Jun 9.

Authors

Abed Zahedi Bialvaei¹, Hossein Samadi Kafil², Mohammad Asgharzadeh³

Affiliations

¹ Infectious Disease and Tropical Medicine Research Center.
² Drug Applied Research Center, Faculty of Medical Sciences.
³ Biotechnology Research Center, Tabriz University of Medical Sciences, Iran.

PMID: 26060290
DOI: 10.1093/cid/civ459

No abstract available

Publication types

Letter

MeSH terms

Antitubercular Agents / economics*
Antitubercular Agents / therapeutic use*
Diagnostic Tests, Routine / economics*
Diagnostic Tests, Routine / methods*
Health Care Costs*
Humans
Iran / epidemiology
Tuberculosis, Multidrug-Resistant / diagnosis*
Tuberculosis, Multidrug-Resistant / drug therapy*
Tuberculosis, Multidrug-Resistant / epidemiology
Tuberculosis, Multidrug-Resistant / transmission

Substances

Antitubercular Agents